{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:22:47Z","timestamp":1788481367736,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.tranon.2024.101958","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T10:03:06Z","timestamp":1713952986000},"page":"101958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65"],"prefix":"10.1016","volume":"45","author":[{"given":"Qiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongge","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1803-8020","authenticated-orcid":false,"given":"Yukun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0001","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2024.101958_bib0002","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1097\/NCC.0000000000000606","article-title":"Quality of life in non-muscle-invasive bladder cancer survivors: a systematic review","volume":"42","author":"Jung","year":"2019","journal-title":"Cancer Nurs."},{"issue":"2","key":"10.1016\/j.tranon.2024.101958_bib0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2024.101958_bib0004","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2024.101958_bib0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/OTT.S283891","article-title":"The development of non-invasive diagnostic tools in bladder cancer","author":"Schulz","year":"2022","journal-title":"Onco Targets. Ther."},{"key":"10.1016\/j.tranon.2024.101958_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2019.04.002","article-title":"Management of metastatic bladder cancer","volume":"76","author":"Nadal","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0007","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cancers13010131","article-title":"Immune checkpoint inhibitors for the treatment of bladder cancer","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0008","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","article-title":"Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes","volume":"17","author":"Meeks","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","article-title":"The role of ubiquitination in tumorigenesis and targeted drug discovery","volume":"5","author":"Deng","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0010","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/s41467-022-30376-7","article-title":"Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates","volume":"13","author":"Trulsson","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1878-0261.12596","article-title":"Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein","volume":"14","author":"Yuan","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tranon.2024.101958_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.944089","article-title":"Insights into the properties, biological functions, and regulation of USP21","volume":"13","author":"An","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.tranon.2024.101958_bib0013","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/jcsm.12777","article-title":"Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes","volume":"12","author":"Kim","year":"2021","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"issue":"19\u201320","key":"10.1016\/j.tranon.2024.101958_bib0014","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.326314.119","article-title":"USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation","volume":"33","author":"Hou","year":"2019","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.tranon.2024.101958_bib0015","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.celrep.2019.02.054","article-title":"FOXM1 deubiquitination by USP21 regulates cell cycle progression and paclitaxel sensitivity in basal-like breast cancer","volume":"26","author":"Arceci","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/cancers12010207","article-title":"Ubiquitin-specific protease 21 promotes colorectal cancer metastasis by acting as a Fra-1 deubiquitinase","volume":"12","author":"Yun","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2024.101958_bib0017","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2147\/OTT.S124795","article-title":"USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma","author":"Chen","year":"2017","journal-title":"Onco Targets. Ther."},{"key":"10.1016\/j.tranon.2024.101958_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.02.005","article-title":"Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development","volume":"158","author":"Jeon","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0019","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/biomedicines9050492","article-title":"20-Hydroxyecdysone, from plant extracts to clinical use: therapeutic potential for the treatment of neuromuscular, cardio-metabolic and respiratory diseases","volume":"9","author":"Dinan","year":"2021","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12964-020-00620-y","article-title":"G protein-coupled receptors function as cell membrane receptors for the steroid hormone 20-hydroxyecdysone","volume":"18","author":"Zhao","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"7","key":"10.1016\/j.tranon.2024.101958_bib0021","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3390\/biomedicines11072071","article-title":"Dietary supplementation with 20-hydroxyecdysone ameliorates hepatic steatosis and reduces white adipose tissue mass in ovariectomized rats fed a high-fat, high-fructose diet","volume":"11","author":"Buniam","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0022","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.3892\/mmr.2017.7389","article-title":"Beneficial effect of 20hydroxyecdysone exerted by modulating antioxidants and inflammatory cytokine levels in collageninduced arthritis: a model for rheumatoid arthritis","volume":"16","author":"Sun","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tranon.2024.101958_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109479","article-title":"Proapoptotic and proautophagic activity of 20-hydroxyecdysone in breast cancer cells in vitro","volume":"342","author":"Romaniuk-Drapa\u0142a","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0024","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/metabo13050656","article-title":"20-Hydroxyecdysone confers antioxidant and antineoplastic properties in human non-small cell lung cancer cells","volume":"13","author":"Shuvalov","year":"2023","journal-title":"Metabolites."},{"issue":"7","key":"10.1016\/j.tranon.2024.101958_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","article-title":"Differential analysis of RNA-seq incorporating quantification uncertainty","volume":"14","author":"Pimentel","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tranon.2024.101958_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-020-03824-8","article-title":"Identification of novel alternative splicing biomarkers for breast cancer with LC\/MS\/MS and RNA-Seq","volume":"21","author":"Zhang","year":"2020","journal-title":"BMC Bioinform.."},{"issue":"4","key":"10.1016\/j.tranon.2024.101958_bib0027","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182091","article-title":"Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia","volume":"217","author":"Tang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tranon.2024.101958_bib0028","doi-asserted-by":"crossref","unstructured":"Mao Y., Peng X., Xue P., et al. Network pharmacology study on the pharmacological mechanism of cinobufotalin injection against lung cancer. Evidence-Based Complementary and Alternative Medicine, 2020, 2020.","DOI":"10.1155\/2020\/1246742"},{"key":"10.1016\/j.tranon.2024.101958_bib0029","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12272-020-01265-8","article-title":"Therapeutic effects of ginsenosides on breast cancer growth and metastasis","volume":"43","author":"Jin","year":"2020","journal-title":"Arch. Pharm. Res."},{"issue":"18","key":"10.1016\/j.tranon.2024.101958_bib0030","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/onc.2013.179","article-title":"Brd4 maintains constitutively active NF-\u03baB in cancer cells by binding to acetylated RelA","volume":"33","author":"Zou","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.tranon.2024.101958_bib0031","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s43018-019-0021-y","article-title":"MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination","volume":"1","author":"Cong","year":"2020","journal-title":"Nat. Cancer"},{"issue":"11","key":"10.1016\/j.tranon.2024.101958_bib0032","article-title":"ETV4 mediated tumor-associated neutrophil infiltration facilitates lymphangiogenesis and lymphatic metastasis of bladder cancer","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0033","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cac2.12284","article-title":"HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-Dependent transcriptional program","volume":"42","author":"Huang","year":"2022","journal-title":"Cancer Commun."},{"issue":"10","key":"10.1016\/j.tranon.2024.101958_bib0034","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.canlet.2016.08.015","article-title":"Long non-coding RNA UCA1 promotes cisplatin\/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells","volume":"382","author":"Pan","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0036","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cbdd.13860","article-title":"Caspase-3: a primary target for natural and synthetic compounds for cancer therapy","volume":"98","author":"Yadav","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.tranon.2024.101958_bib0037","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2024.101958_bib0038","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jb\/mvy047","article-title":"Involvement of partial EMT in cancer progression","volume":"164","author":"Saitoh","year":"2018","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0039","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mc.22300","article-title":"Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer","volume":"55","author":"Islam","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"6","key":"10.1016\/j.tranon.2024.101958_bib0041","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jdiacomp.2012.06.014","article-title":"20-Hydroxyecdysone attenuates TGF-\u03b21-induced renal cellular fibrosis in proximal tubule cells","volume":"26","author":"Hung","year":"2012","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.tranon.2024.101958_bib0042","doi-asserted-by":"crossref","unstructured":"Odero-Marah V., Hawsawi O., Henderson V., et al. Epithelial-mesenchymal transition (EMT) and prostate cancer. Cell & molecular biology of prostate cancer: updates, insights and new frontiers, 2018: 101\u2013110.","DOI":"10.1007\/978-3-319-95693-0_6"},{"issue":"3","key":"10.1016\/j.tranon.2024.101958_bib0043","article-title":"Long non-coding RNA LINC00511\/miR-150\/MMP13 axis promotes breast cancer proliferation, migration and invasion","volume":"1867","author":"Shi","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.tranon.2024.101958_bib0044","first-page":"14","article-title":"E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.tranon.2024.101958_bib0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/13543776.2015.1056737","article-title":"Deubiquitinases (DUBs) and DUB inhibitors: a patent review","volume":"25","author":"Farshi","year":"2015","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"19","key":"10.1016\/j.tranon.2024.101958_bib0046","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","article-title":"Deubiquitinases in cancer: new functions and therapeutic options","volume":"31","author":"Fraile","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0047","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s12276-019-0356-6","article-title":"The USP21\/YY1\/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer","volume":"52","author":"Xu","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0048","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbcan.2018.10.002","article-title":"NF-kappaB-inducing kinase in cancer","volume":"1871","author":"Maubach","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0049","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2741\/2900","article-title":"NF-kappaB: a potential target for cancer chemoprevention and therapy","volume":"13","author":"Sarkar","year":"2008","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.tranon.2024.101958_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.bjc.6603878","article-title":"High expression of RelA\/p65 is associated with activation of nuclear factor-\u03baB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis","volume":"97","author":"Weichert","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2024.101958_bib0051","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-009-0267-2","article-title":"NF-\u03baB and cancer: how intimate is this relationship","volume":"336","author":"Prasad","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.tranon.2024.101958_bib0052","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clon.2006.11.013","article-title":"The transcription factor nuclear factor-kappa B and cancer","volume":"19","author":"Escarcega","year":"2007","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0053","doi-asserted-by":"crossref","first-page":"40723","DOI":"10.1038\/srep40723","article-title":"NF-\u03baB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo","volume":"7","author":"Cui","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.tranon.2024.101958_bib0054","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.4143\/crt.2015.381","article-title":"TRIM29 overexpression promotes proliferation and survival of bladder cancer cells through NF-\u03baB signaling","volume":"48","author":"Tan","year":"2016","journal-title":"Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.tranon.2024.101958_bib0055","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/onc.2009.410","article-title":"Her2 activates NF-\u03baB and induces invasion through the canonical pathway involving IKK\u03b1","volume":"29","author":"Merkhofer","year":"2010","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.tranon.2024.101958_bib0056","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2024.101958_bib0057","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-\u03baB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0058","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-021-01935-5","article-title":"ROC1 promotes the malignant progression of bladder cancer by regulating p-I\u03baB\u03b1\/NF-\u03baB signaling","volume":"40","author":"Wu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2024.101958_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113778","article-title":"Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNF\u03b1\/NF\u039aB and iNOS\/NO pathways","volume":"176","author":"Girouard","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.tranon.2024.101958_bib0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tranon.2024.101958_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109543","article-title":"E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer","volume":"69","author":"Jin","year":"2020","journal-title":"Cell. Signal."},{"issue":"24","key":"10.1016\/j.tranon.2024.101958_bib0062","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1158\/1078-0432.CCR-08-1539","article-title":"Nuclear factor-\u03baB p65\/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells","volume":"14","author":"Pan","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0063","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/cdd.2009.168","article-title":"Regulation of death receptor signaling by the ubiquitin system","volume":"17","author":"Wertz","year":"2010","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.tranon.2024.101958_bib0064","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.molcel.2009.02.011","article-title":"Linkage-specific avidity defines the lysine 63-linked polyubiquitin-binding preference of rap80","volume":"33","author":"Sims","year":"2009","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.tranon.2024.101958_bib0065","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/onc.2013.135","article-title":"Inhibitor of growth 4 induces NF\u03baB\/p65 ubiquitin-dependent degradation","volume":"33","author":"Hou","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2024.101958_bib0066","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPAR\u03b3 is an E3 ligase that induces the degradation of NF\u03baB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.tranon.2024.101958_bib0067","first-page":"4930","article-title":"Deubiquitination and stabilization of IL-33 by USP21","volume":"7","author":"Tao","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523324000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T09:21:17Z","timestamp":1716369677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523324000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":67,"alternative-id":["S1936523324000858"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2024.101958","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2024.101958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101958"}}